Status:
COMPLETED
Retrospective Analysis of Veritas in Breast Reconstruction
Lead Sponsor:
Baxter Healthcare Corporation
Collaborating Sponsors:
Synovis Surgical Innovations
Conditions:
Seroma
Necrosis
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective data collection of the use of Veritas in breast reconstruction surgery
Detailed Description
This is a multi-center study to retrospectively collect data on the use of Veritas Collagen Matrix in breast reconstruction. Data will be collected on post-operative complications in immediate breast ...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Patients who underwent mastectomy with immediate breast reconstruction using Veritas collagen matrix
- Patients who underwent mastectomy with single stage procedures or two-stage procedures using Veritas collagen matrix
Exclusion
- Patients who underwent delayed breast reconstruction
- Reconstruction with something other than Veritas collagen matrix
- Breasts that were created with DIEP or TRAM procedures
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01454713
Start Date
October 1 2010
End Date
October 1 2011
Last Update
April 5 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mark M. Mofid, MD
San Diego, California, United States, 92037
2
Michael Meininger, MD
Troy, Michigan, United States, 48084
3
Martin Lacey, MD
Saint Paul, Minnesota, United States, 55101